PMGC Holdings Inc. (ELAB) vs Jupiter Neurosciences, Inc. (JUNS)

A side-by-side comparison of PMGC Holdings Inc. and Jupiter Neurosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ELAB

PMGC Holdings Inc.

$1M

$3.28HealthcareDelayed quote: Oct 6, 2026, 11:26 AM EDT

JUNS

Jupiter Neurosciences, Inc.

$1M

$2.40HealthcareDelayed quote: Oct 6, 2026, 11:30 AM EDT

Total return — ELAB vs JUNS

growth of $100 · dividends reinvested · last 2y

ELAB -100.0% (-99.2%/yr)JUNS -99.4% (-92.3%/yr)JUNS compounded faster over this window

Log scale — wide-divergence pair

ELAB JUNS

ELAB vs JUNS: by the numbers

•ELAB is the larger company ($1M vs $1M market cap).
•Both run net losses; ELAB's is the smaller (-522.97% vs -14220.12% net margin).

Metrics side by side

Valuation

Metric	ELAB	JUNS
P/S ratio	0.58	17.98
P/B ratio	0.09	N/A

Profitability

Metric	ELAB	JUNS
Gross margin	10.31%	88.34%
Operating margin	-1250.11%	-40873.19%
Net margin	-522.97%	-14220.12%
ROE	-80.57%	N/A
ROIC	N/A	-709.40%

Growth (annualized)

Metric	ELAB	JUNS
Revenue CAGR (5Y)	N/A	-47.77%

Go deeper

Full ELAB analysis Full JUNS analysis Interactive comparison tool

Dig into the metrics

PMGC ROE Jupiter Neurosciences ROE PMGC operating margin Jupiter Neurosciences operating margin PMGC revenue growth Jupiter Neurosciences revenue growth PMGC free cash flow Jupiter Neurosciences free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.